These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
34. [The effect of neuromuscular blocking agents on the pre-and postjunctional receptors at the neuromuscular junction]. Amaki Y Masui; 1985 Sep; 34(9):1185-93. PubMed ID: 3003417 [No Abstract] [Full Text] [Related]
35. Neuromuscular blockade in children. Almeida JF; Kalil Filho WJ; Troster EJ Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(3):105-10. PubMed ID: 10983014 [TBL] [Abstract][Full Text] [Related]
36. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Viby-Mogensen J; Engbaek J; Eriksson LI; Gramstad L; Jensen E; Jensen FS; Koscielniak-Nielsen Z; Skovgaard LT; Ostergaard D Acta Anaesthesiol Scand; 1996 Jan; 40(1):59-74. PubMed ID: 8904261 [TBL] [Abstract][Full Text] [Related]
37. Neuromuscular pharmacology update. Tsai SK; Lee C Ma Zui Xue Za Zhi; 1991 Dec; 29(4):721-7. PubMed ID: 1666167 [No Abstract] [Full Text] [Related]
38. Should a neuromuscular block be reversed? Eriksson L Acta Anaesthesiol Scand Suppl; 1997; 110():101. PubMed ID: 9248549 [No Abstract] [Full Text] [Related]
40. Pharmacology of neuromuscular blocking agents in the intensive care unit. Hanson CW Crit Care Clin; 1994 Oct; 10(4):779-97. PubMed ID: 8000926 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]